HUP0100433A3 - Orally administrable solid ribavirin dosage forms and process for producing them - Google Patents

Orally administrable solid ribavirin dosage forms and process for producing them

Info

Publication number
HUP0100433A3
HUP0100433A3 HU0100433A HUP0100433A HUP0100433A3 HU P0100433 A3 HUP0100433 A3 HU P0100433A3 HU 0100433 A HU0100433 A HU 0100433A HU P0100433 A HUP0100433 A HU P0100433A HU P0100433 A3 HUP0100433 A3 HU P0100433A3
Authority
HU
Hungary
Prior art keywords
producing
dosage forms
orally administrable
administrable solid
ribavirin dosage
Prior art date
Application number
HU0100433A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27130673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0100433(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/997,169 external-priority patent/US5916594A/en
Priority claimed from US08/997,172 external-priority patent/US5914128A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of HUP0100433A2 publication Critical patent/HUP0100433A2/hu
Publication of HUP0100433A3 publication Critical patent/HUP0100433A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0100433A 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for producing them HUP0100433A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/997,169 US5916594A (en) 1997-12-22 1997-12-22 Process of making solid ribavirin dosage forms
US08/997,172 US5914128A (en) 1997-12-22 1997-12-22 Orally administrable solid dosage form
PCT/US1998/026222 WO1999032128A1 (en) 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for making them

Publications (2)

Publication Number Publication Date
HUP0100433A2 HUP0100433A2 (hu) 2001-12-28
HUP0100433A3 true HUP0100433A3 (en) 2003-01-28

Family

ID=27130673

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100433A HUP0100433A3 (en) 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for producing them

Country Status (26)

Country Link
US (3) US6337090B1 (enExample)
EP (2) EP0991415B1 (enExample)
JP (2) JP2001526234A (enExample)
KR (1) KR100575389B1 (enExample)
CN (1) CN1155388C (enExample)
AR (1) AR008977A1 (enExample)
AT (1) ATE234103T1 (enExample)
AU (1) AU762826B2 (enExample)
BR (1) BR9814367A (enExample)
CA (4) CA2365412C (enExample)
CO (1) CO4970774A1 (enExample)
DE (1) DE69812094T2 (enExample)
DK (1) DK0991415T3 (enExample)
ES (1) ES2191987T3 (enExample)
HU (1) HUP0100433A3 (enExample)
IL (1) IL136549A (enExample)
MY (1) MY119656A (enExample)
NO (1) NO20003234L (enExample)
NZ (1) NZ504994A (enExample)
PE (1) PE20000066A1 (enExample)
PL (1) PL190267B1 (enExample)
PT (1) PT991415E (enExample)
SK (1) SK284520B6 (enExample)
TW (1) TW575436B (enExample)
WO (1) WO1999032128A1 (enExample)
ZA (1) ZA9811726B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE234103T1 (de) * 1997-12-22 2003-03-15 Schering Corp Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
EP1263341B1 (en) * 2000-03-06 2008-06-11 Salient Surgical Technologies, Inc. Fluid delivery system and controller for electrosurgical devices
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
KR20030020137A (ko) * 2001-09-03 2003-03-08 진양제약주식회사 리바비린 건조시럽제
RU2004116821A (ru) * 2001-11-02 2005-04-20 Сандоз Инк. (Us) Способ получения быстрорастворимой композиции с высоким содержанием рибавирина
DE10227148A1 (de) * 2002-06-18 2004-01-08 Biopartners Gmbh Verwendung von Ribavirin zur Herstellung einer pharmazeutischen Zusammensetzung gegen Bunyaviridae
US7538094B2 (en) * 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
US20040142903A1 (en) * 2003-01-16 2004-07-22 Par Pharmaceutical Inc. Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
CN1980678A (zh) * 2003-03-28 2007-06-13 法莫赛特股份有限公司 治疗黄病毒感染的化合物
TR200701424T1 (tr) * 2004-09-09 2007-04-24 Bayer Healthcare Ag Suda çözünebilen katı dozaj formunda farmasötik bileşim.
US7723310B2 (en) * 2004-10-18 2010-05-25 Three Rivers Pharmaceuticals, Llc Large dose ribavirin formulations
US8062670B2 (en) * 2005-08-05 2011-11-22 3M Innovative Properties Company Compositions exhibiting improved flowability
EP2054076A2 (en) * 2006-08-21 2009-05-06 United Therapeutics Corporation Combination therapy for treatment of viral infections
WO2009142852A2 (en) * 2008-05-22 2009-11-26 3M Innovative Properties Company Process for manufacturing flowable powder drug compositions
WO2009158300A1 (en) * 2008-06-26 2009-12-30 3M Innovative Properties Company Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
EP2309984B1 (en) * 2008-07-02 2018-04-11 3M Innovative Properties Company Method of making a dry powder pharmaceutical composition
EP2295037A1 (en) 2009-09-11 2011-03-16 Ratiopharm GmbH Pharmaceutical formulation containing Ribavirin
US10363453B2 (en) 2011-02-07 2019-07-30 New Balance Athletics, Inc. Systems and methods for monitoring athletic and physiological performance
CA2752008A1 (en) 2011-09-13 2013-03-13 Universite De Montreal Combination therapy using ribavirin as elf4e inhibitor
CN106389363A (zh) * 2016-10-18 2017-02-15 广东肇庆星湖生物科技股份有限公司 一种利巴韦林口服固体制剂及其制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
DE2735600A1 (de) * 1977-08-06 1979-02-15 Dynamit Nobel Ag Verfahren zur herstellung von phthalid
JPS57146593A (en) * 1981-03-09 1982-09-10 Ajinomoto Co Inc Preparation of ribofuranosyltriazole derivative
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4681765A (en) * 1984-09-13 1987-07-21 American Home Products Corporation Rapid releasing triamterene containing gelatin capsule dosage forms for once daily antihypertensive use
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
JPS63216820A (ja) * 1987-03-05 1988-09-09 Chugai Pharmaceut Co Ltd 抗ウイルス剤
GB8800276D0 (en) * 1988-01-07 1988-02-10 Univ Liverpool Medical treatment
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
US5122517A (en) * 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
JP2908844B2 (ja) * 1990-06-29 1999-06-21 ヤマサ醤油株式会社 抗ウイルス剤
JPH07502740A (ja) * 1992-01-06 1995-03-23 ザ・ウエルカム・ファウンデーション・リミテッド 治療用ヌクレオシド
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
JPH06298665A (ja) * 1993-04-14 1994-10-25 Toray Ind Inc 抗ウイルス剤
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
US5492692A (en) * 1993-08-17 1996-02-20 University Of Kentucky Research Foundation Coated products with potent anti-HIV and antimicrobial properties
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CA2135669A1 (en) 1994-11-10 1996-05-11 Nils O. Johannesson Ribavirin as hepato (liver) protecting agent
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6106865A (en) * 1995-01-09 2000-08-22 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
CA2213700C (en) * 1995-02-28 2002-04-02 Hoechst Marion Roussel, Inc. Pharmaceutical composition for piperidinoalkanol compounds
US6387365B1 (en) * 1995-05-19 2002-05-14 Schering Corporation Combination therapy for chronic hepatitis C infection
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
US6172046B1 (en) * 1997-09-21 2001-01-09 Schering Corporation Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
ATE234103T1 (de) * 1997-12-22 2003-03-15 Schering Corp Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung

Also Published As

Publication number Publication date
NO20003234D0 (no) 2000-06-21
CA2323849C (en) 2002-06-11
AR008977A1 (es) 2000-03-08
US6051252A (en) 2000-04-18
CA2287056C (en) 2000-08-15
EP1321147A1 (en) 2003-06-25
KR20010033441A (ko) 2001-04-25
CN1155388C (zh) 2004-06-30
BR9814367A (pt) 2000-10-17
PL190267B1 (pl) 2005-11-30
AU762826B2 (en) 2003-07-03
DK0991415T3 (da) 2003-06-16
CA2365412C (en) 2002-09-17
CA2365412A1 (en) 1999-07-01
KR100575389B1 (ko) 2006-05-03
AU2199199A (en) 1999-07-12
DE69812094D1 (de) 2003-04-17
HUP0100433A2 (hu) 2001-12-28
ZA9811726B (en) 1999-06-21
ES2191987T3 (es) 2003-09-16
HK1034674A1 (en) 2001-11-02
ATE234103T1 (de) 2003-03-15
TW575436B (en) 2004-02-11
PT991415E (pt) 2003-06-30
CA2300452C (en) 2000-11-28
DE69812094T2 (de) 2003-12-24
SK284520B6 (sk) 2005-05-05
IL136549A0 (en) 2001-06-14
US6337090B1 (en) 2002-01-08
JP2006083189A (ja) 2006-03-30
EP0991415A1 (en) 2000-04-12
PE20000066A1 (es) 2000-02-09
NO20003234L (no) 2000-08-21
MY119656A (en) 2005-06-30
CA2323849A1 (en) 1999-07-01
PL341230A1 (en) 2001-03-26
CO4970774A1 (es) 2000-11-07
JP2001526234A (ja) 2001-12-18
CA2287056A1 (en) 1999-07-01
NZ504994A (en) 2002-10-25
US6335032B1 (en) 2002-01-01
CA2300452A1 (en) 1999-07-01
EP0991415B1 (en) 2003-03-12
SK8942000A3 (en) 2001-04-09
WO1999032128A1 (en) 1999-07-01
IL136549A (en) 2005-05-17
CN1283117A (zh) 2001-02-07

Similar Documents

Publication Publication Date Title
HUP0100433A3 (en) Orally administrable solid ribavirin dosage forms and process for producing them
ZA965222B (en) Pharmaceutical orally applicable composition
CZ11498A3 (cs) Střela a způsob její výroby
HUP9802913A3 (en) Bioadhesive solid dosage form
SI0914119T1 (en) Process for forming solid oral dosage forms of valsartan
ZA987551B (en) Solid pharmaceutical dosage forms
ZA953627B (en) Controlled-release dosage forms of azithromycin
GB2310802A (en) Chewable dosage forms
EP0694307A4 (en) MEDICINE AGAINST ATOPIC DISEASES
HU9603484D0 (en) Pharmaceutical compositions and process for producing symptom-transduction
EP1021170A4 (en) MARKING OF ORAL TAKEN PRODUCTS
IL123614A0 (en) Chewable tablet
ZA9510427B (en) Pharmaceutical orally applicable composition
HUP9900793A3 (en) Cementitious board and prouss and die for its manufacturing
HUP9900143A3 (en) Pharmaceutically useful 3-pyridil-compounds
EP1131052A4 (en) VAGINALLY ADMINISTRATIVE TABLETS CONTAINING PROGESTERONE AND METHOD FOR THE PRODUCTION THEREOF
HUP9903180A3 (en) Granulates of hexahydropyrazine derivatives which can be administered orally and process for producing them
HUP0003566A3 (en) Process for producing dosage form and the obtained product
ZA978219B (en) The production of solid pharmaceutical forms
HU9701137D0 (en) Process for producing pharmaceutical intermedier
AU1152800A (en) Orally applicable therapeutic dosage form which spontaneously disintegrates uponcontact with a liquid and method for producing the same
GB9821967D0 (en) Process for the preparation of orally active cephalosporin antibiotic-cefixim
HUP9904259A3 (en) Process for producing solid dosage forms
HU9801024D0 (en) Process for producing pharmaceutical intermediate
GB2315229B (en) Internal mixers

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees